17699867 |
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
Hom, G,
Antonescu, CR,
Guo, T,
Agaram, NP,
Veach, D,
Singer, S,
Schwartz, GK,
Besmer, P,
Maki, RG,
Clarkson, BD,
D'Adamo, D,
Wong, GC,
DeMatteo, RP
|
Clin. Cancer Res. |
2007 |
17363509 |
Resistance to c-KIT kinase inhibitors conferred by V654A mutation
Griffith, R,
Odell, AF,
Roberts, KG,
Baleato, RM,
Lyons, AB,
Ashman, LK,
Byrnes, EM
|
Mol. Cancer Ther. |
2007 |
28478525 |
Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
Morales-Barrera, R,
Carles, J,
Suárez, C,
García-Valverde, A,
Olivares, D,
Valverde, C,
George, S,
Serrano, C
|
Target Oncol |
2017 |
30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Heinrich, MC,
Ketzer, J,
Bauer, S,
Zhu, M,
Presnell, A,
Raut, CP,
George, S,
Mannan, AM,
Serrano, C,
Yu, C,
Sicinska, E,
Tao, DL,
Rubin, BP,
Fletcher, JA,
Mariño-Enríquez, A,
Demetri, GD,
Eilers, G,
Czaplinski, JT,
McKinley, A
|
Br. J. Cancer |
2019 |